Request Sample Inquiry
Precision Medicine Software Market

Precision medicine software Market

Precision medicine software Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

134

Base Year:

2022

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1353

Segments Covered
  • By Delivery Mode By Delivery Mode On-premise Delivery Mode, Cloud-based Delivery Mode
  • By End User By End User Healthcare Providers, Research Centers and Academic Institutes, Pharmaceutical and Biotechnology Companies, Other End Users (non-profit organizations and diagnostic companies)
  • By Application By Application Oncology, Pharmacogenomics, Rare Diseases, Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1312.29 Million
Revenue 2030Revenue 2030: USD 3112.52 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 11.40%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Precision medicine software Market by Delivery Mode by End User by Application - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Precision medicine software supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:


  • Precision medicine software market size at regional and country level
  • Key industry players and their market share and Precision medicine software market-specific sales/revenue
  • Understanding of the Precision medicine software supply chain and overall ecosystem

Data Triangulation and Market Size Estimations

After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Precision medicine software market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market.  The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Precision medicine software market. 

FAQ
Frequently Asked Question
  • The global Precision medicine software valued at USD 1312.29 Million in 2022 and is expected to reach USD 3112.52 Million in 2030 growing at a CAGR of 11.40%.

  • The prominent players in the market are Syapse, Inc., 2bprecise, LLC, Fabric Genomics, Inc., Foundation Medicine, Inc., Sophia Genetics Sa, Pieriandx, Inc., N-Of-One, Inc. (A Subsidiary of Qiagen N.V.), Human Longevity, Inc., Translational Software Inc., Sunquest Information Systems, Inc., Gene42, Inc., Lifeomic Health, LLC.

  • The market is project to grow at a CAGR of 11.40% between 2023 and 2030.

  • The driving factors of the Precision medicine software include

    • Growing emphasis on delivering personalized medicine in hospitals

  • North America was the leading regional segment of the Precision medicine software in 2022.